About us
Our research has a strong focus on early detection and early treatment of common diseases. It covers fundamental research on a molecular level, development of new medical devices and software tools, and translates these results to clinical applications that can be used in daily routine.
read moreAbout us
Our mission is to bridge the gap between research and practice and to help shape the future of healthcare. We use technology to make healthcare more affordable by increasing automation of diagnostic and therapeutic procedures, thus freeing manpower for those areas in patient care in which the "human touch" is most needed.
The five fundamental science groups cover:
- ultrasound (MUSIC),
- biomedical MR (BioMR),
- diagnostic image analysis (DIAG),
- nuclear medicine (NucMed)
- advanced x-ray tomographic imaging (AXTI).
Clinical research is mainly focused on prostate, breast, chest and vascular disease.
Our researchers Radiology and Nuclear Medicine
A list of researchers connected to this department.
read more-
Elina Stamatelatou won first price oral presentation30 May 2022
-
Mathias Prokop appointed department head of Radiology UMCGHe also remains department head of Imaging Radboudumc11 April 2022
-
Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AIAward for safer pregnancies using AI1 December 2021
Radboudumc Technology Center Imaging
This technology center provides cutting-edge technology and service for imaging-related preclinical and clinical research questions. This covers the spectrum from molecule to man to population.
read morePatient care
This department also offers patient care. read more (in Dutch)Getting there
Entrance: Radboudumc main entrance (hoofdingang)
Building: D
Floor: -1
Route: 757
Getting there
Visiting address
Radboudumc main entrance
Geert Grooteplein Zuid 10
6525 GA Nijmegen
Postal address
Post 766, Radiology
P.O. Box 9101
6500 HB Nijmegen
The Netherlands
Directions
Dosimetry Core Unit
The Dosimetry Core Unit is part of the Department of Medical Imaging. We support effective and safe radionuclide therapy for cancer patients. We perform translational research, covering the whole range from bench to bedside.
read more